A detailed history of Israel Englander (Millennium Management LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Millennium Management LLC holds 41,700 shares of TEVA stock, worth $726,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,700
Previous 10,748,785 99.61%
Holding current value
$726,831
Previous $152 Million 99.55%
% of portfolio
0.0%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $17.6 Million - $24 Million
1,379,392 Added 12.83%
12,128,177 $197 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $46.1 Million - $62.4 Million
-4,322,067 Reduced 28.68%
10,748,785 $152 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $8.45 Million - $11.1 Million
1,040,783 Added 7.42%
15,070,852 $157 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $56.4 Million - $74.2 Million
7,835,223 Added 126.48%
14,030,069 $106 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $43.1 Million - $58.6 Million
5,158,012 Added 497.48%
6,194,846 $54.8 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $3.87 Million - $4.61 Million
-486,456 Reduced 31.93%
1,036,834 $9.46 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $58.7 Million - $102 Million
-8,563,015 Reduced 84.9%
1,523,290 $12.3 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $9.94 Million - $14 Million
-1,346,502 Reduced 11.78%
10,086,305 $75.8 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $64.2 Million - $82.2 Million
8,752,890 Added 326.61%
11,432,807 $107 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $7.72 Million - $9.96 Million
977,158 Added 57.39%
2,679,917 $21.5 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $12.9 Million - $15.6 Million
1,534,493 Added 911.94%
1,702,759 $16.6 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $12.5 Million - $14.6 Million
-1,259,810 Reduced 88.22%
168,266 $1.67 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $11.2 Million - $13.9 Million
1,081,801 Added 312.41%
1,428,076 $16.5 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $6.29 Million - $8.07 Million
-730,775 Reduced 67.85%
346,275 $3.34 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $8.23 Million - $12.2 Million
960,583 Added 824.77%
1,077,050 $9.7 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $8.87 Million - $14.3 Million
-1,092,810 Reduced 90.37%
116,467 $1.44 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $2.74 Million - $5.51 Million
409,411 Added 51.18%
1,209,277 $10.9 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $7.18 Million - $11.8 Million
-1,100,093 Reduced 57.9%
799,866 $7.84 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $11.6 Million - $18.1 Million
1,888,057 Added 15863.36%
1,899,959 $13.1 Million
Q2 2019

Aug 15, 2019

SELL
$8.12 - $15.72 $4.31 Million - $8.35 Million
-531,005 Reduced 97.81%
11,902 $110,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $4.13 Million - $7.99 Million
508,106 Added 1460.03%
542,907 $6.65 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $8.24 Million - $10.6 Million
-528,918 Reduced 93.83%
34,801 $546,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $3.07 Million - $5.02 Million
-210,542 Reduced 27.19%
563,719 $8.69 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $102 Million - $124 Million
-4,851,590 Reduced 86.24%
774,261 $16.7 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $93.1 Million - $137 Million
5,549,041 Added 7224.37%
5,625,851 $137 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $48.2 Million - $63.8 Million
-2,889,126 Reduced 97.41%
76,810 $1.31 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $12 Million - $20.5 Million
1,071,583 Added 56.57%
2,965,936 $56.2 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $29.2 Million - $60.9 Million
1,894,353
1,894,353 $33.3 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.